
TPD & Induced Proximity Pharma Partnering Summit
Newsletters and Deep Dive digital magazine
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
In a post-ASCO 2025 conversation, pharmaphorum web editor Nicole Raleigh spoke with Dr Pamela Tenaerts, chief medical officer at Medable.
Developments in the oncology space in 2024 brought hope to both industry and patients.
Marcus Evans is proud to announce the Evolution Summit September 2025, an exclusive, invitation-only event bringing together leading clinical trial executives, innovative suppliers
Transforming Research & Development with Faster, More Precise Spatial Insights